SANUWAVE Health, Inc. (SNWV)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$4.38-1.57%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
Broken: Primary pillar broken — Deliver Q2 2026 revenue growth of 10-15% to about $9 million: rev -3.0% vs 10% target.
SANUWAVE aims to grow revenue to about $53 million in 2026. Q2 revenue should rise 10-15% to about $9 million. The company is fixing past tax issues. These steps could help it recover and grow.
The company missed earnings several times recently. Management is unstable with leadership changes. Revenue growth may slow or miss targets. Tax problems could hurt finances further.
The price is about 1% above our fair value near $11. Analysts expect about 29% revenue growth. We see risk from recent earnings misses and management issues.
Breaks if: Full year 2026 revenue falls below $51 million
Deliver full year 2026 revenue in the range of $51.0 to $55.0 million, representing a 16-25% increase over 2025.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity. The company is navigating a challenging environment with mixed recent financial performance and high near-term risks, but it operates within a sector that has favorable tailwinds.
The market appears to have priced in a level of fragility due to weak execution quality, but the current valuation is considered cheap compared to peers. There is an expectations gap, indicating that the market may not fully account for potential upside from sector momentum.
Fundamentals are likely to remain under pressure in the near term, given the elevated risk of an earnings miss and mixed results from management's priorities. Recent financial performance has been strong overall, but the company has faced consecutive earnings misses, which raises concerns.
The long-term thesis hinges on management's ability to meet revenue guidance and improve execution quality. Additionally, sector performance, particularly from major players, will be crucial in determining SNWV's trajectory.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 3 of last 3 quarters. Management reiterated full year 2026 revenue guidance of $51.0-55.0 million, representing a 16-25% increase over 2025 full year revenue of approximately $44.5 million. The trajectory is mixed as Q2 2026 revenue of $9.7 million was down 3% year-over-year, indicating challenges in meeting the full year target.
“Company reiterates full year 2026 revenue guidance of $51.0-55.0 million”
“Company provides guidance for revenue growth of 10-15% for Q2 2026 and reiterates full year 2026 revenue guidance of $51.0-55.0 million”
“initiates full year 2026 revenue guidance of 51.0-55.0 million (16-25% increase as compared to full year 2025 revenue)”
Breaks if: Major management changes or instability continue
Breaks if: Q2 2026 revenue growth falls below 10%
Breaks if: Tax liability remains unresolved after one year
Over the next 1 to 3 years, SNWV's performance will depend on overcoming execution challenges while leveraging sector momentum. Not investment advice.